Pages that link to "Q37524119"
Jump to navigation
Jump to search
The following pages link to Fibroblast growth factor-23 and cardiovascular events in CKD. (Q37524119):
Displaying 50 items.
- Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease? (Q27002431) (← links)
- Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability (Q28081407) (← links)
- Vitamin D and anemia: insights into an emerging association (Q28084642) (← links)
- The systemic nature of CKD. (Q30234695) (← links)
- Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients (Q30979522) (← links)
- FGF23 and vascular calcifications: another piece of the puzzle? (Q33358225) (← links)
- High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients (Q33643233) (← links)
- Chronic kidney disease and osteoporosis: evaluation and management (Q33833414) (← links)
- The use of fibroblast growth factor 23 testing in patients with kidney disease (Q33835743) (← links)
- Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline. (Q33873450) (← links)
- Fibroblast growth factor 23, iron and inflammation - are they related in early stages of chronic kidney disease? (Q33904467) (← links)
- Identification of incident CKD stage 3 in research studies (Q33954425) (← links)
- Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients (Q34204949) (← links)
- Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease (Q34421217) (← links)
- Fibroblast growth factor 23 and incident CKD in type 2 diabetes. (Q34828731) (← links)
- Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial (Q35008805) (← links)
- Fibroblast growth factor 23 and risk of incident stroke in community-living adults (Q35019943) (← links)
- Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study (Q35021985) (← links)
- Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease (Q35067500) (← links)
- Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD. (Q35588217) (← links)
- Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study (Q35797940) (← links)
- Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia (Q35893998) (← links)
- Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease. (Q35997370) (← links)
- Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study (Q35998095) (← links)
- Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals (Q36016861) (← links)
- Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study. (Q36085749) (← links)
- The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease (Q36098749) (← links)
- Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. (Q36104887) (← links)
- Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014 (Q36123640) (← links)
- Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings (Q36250305) (← links)
- Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients (Q36269865) (← links)
- Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus (Q36520483) (← links)
- Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. (Q36707848) (← links)
- Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery (Q36711992) (← links)
- High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4. (Q36822751) (← links)
- Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease. (Q37271191) (← links)
- Energy-dense diets increase FGF23, lead to phosphorus retention and promote vascular calcifications in rats (Q37411895) (← links)
- Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy (Q37432867) (← links)
- Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease (Q37681556) (← links)
- Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review (Q37695914) (← links)
- The effect of nephrectomy on Klotho, FGF-23 and bone metabolism (Q37710161) (← links)
- Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond? (Q38185277) (← links)
- The challenge of controlling phosphorus in chronic kidney disease (Q38377286) (← links)
- The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder (Q38584122) (← links)
- Phosphate and FGF-23 homeostasis after kidney transplantation (Q38863874) (← links)
- Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3. (Q38609527) (← links)
- Chronic Kidney Disease-Mineral and Bone Disorder in Asia (Q38635767) (← links)
- Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study (Q38636252) (← links)
- The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study (Q38644586) (← links)
- Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation (Q38762820) (← links)